English
简体中文
Total: £ 56.28
Published Date: 2026-04-07 | Pages: 127 | Tables: 136 | Service & Software
The global Virtual Screening for Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
The North American market for Virtual Screening for Drug Discovery is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Virtual Screening for Drug Discovery is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Virtual Screening for Drug Discovery in Pharmaceutical Company is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Virtual Screening for Drug Discovery include MedChemExpress, TargetMol, OpenEye Scientific, Eurofins Discovery, Sygnature Discovery, Jubilant Biosys, Schrödinger, Inc., Cresset Group, ComputaBio, Profacgen, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Virtual Screening for Drug Discovery market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Virtual Screening for Drug Discovery. The Virtual Screening for Drug Discovery market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Virtual Screening for Drug Discovery market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Virtual Screening for Drug Discovery manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
MedChemExpress
TargetMol
OpenEye Scientific
Eurofins Discovery
Sygnature Discovery
Jubilant Biosys
Schrödinger, Inc.
Cresset Group
ComputaBio
Profacgen
CD ComputaBio
Creative Biolabs
BOC Sciences
CKTTDB
HitGen
WuXi AppTec
LeadBuilder
CSNpharm
ChemNavigator
Segment by Type
Structure-based Virtual Screening (SBVS)
Ligand-based Virtual Screening (LBVS)
Hybrid Methods
Segment by Application
Pharmaceutical Company
Universities and Research Institutions
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Virtual Screening for Drug Discovery companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Virtual Screening for Drug Discovery Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Structure-based Virtual Screening (SBVS)
1.2.3 Ligand-based Virtual Screening (LBVS)
1.2.4 Hybrid Methods
1.3 Market by Application
1.3.1 Global Virtual Screening for Drug Discovery Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Company
1.3.3 Universities and Research Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Virtual Screening for Drug Discovery Market Perspective (2021–2032)
2.2 Global Virtual Screening for Drug Discovery Growth Trends by Region
2.2.1 Global Virtual Screening for Drug Discovery Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Virtual Screening for Drug Discovery Historic Market Size by Region (2021–2026)
2.2.3 Virtual Screening for Drug Discovery Forecasted Market Size by Region (2027–2032)
2.3 Virtual Screening for Drug Discovery Market Dynamics
2.3.1 Virtual Screening for Drug Discovery Industry Trends
2.3.2 Virtual Screening for Drug Discovery Market Drivers
2.3.3 Virtual Screening for Drug Discovery Market Challenges
2.3.4 Virtual Screening for Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Virtual Screening for Drug Discovery Players by Revenue
3.1.1 Global Top Virtual Screening for Drug Discovery Players by Revenue (2021–2026)
3.1.2 Global Virtual Screening for Drug Discovery Revenue Market Share by Players (2021–2026)
3.2 Global Top Virtual Screening for Drug Discovery Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Virtual Screening for Drug Discovery Revenue
3.4 Global Virtual Screening for Drug Discovery Market Concentration Ratio
3.4.1 Global Virtual Screening for Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Virtual Screening for Drug Discovery Revenue in 2025
3.5 Global Key Players of Virtual Screening for Drug Discovery Head Offices and Areas Served
3.6 Global Key Players of Virtual Screening for Drug Discovery, Products and Applications
3.7 Global Key Players of Virtual Screening for Drug Discovery, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Virtual Screening for Drug Discovery Breakdown Data by Type
4.1 Global Virtual Screening for Drug Discovery Historic Market Size by Type (2021–2026)
4.2 Global Virtual Screening for Drug Discovery Forecasted Market Size by Type (2027–2032)
5 Virtual Screening for Drug Discovery Breakdown Data by Application
5.1 Global Virtual Screening for Drug Discovery Historic Market Size by Application (2021–2026)
5.2 Global Virtual Screening for Drug Discovery Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Virtual Screening for Drug Discovery Market Size (2021–2032)
6.2 North America Virtual Screening for Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Virtual Screening for Drug Discovery Market Size by Country (2021–2026)
6.4 North America Virtual Screening for Drug Discovery Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Virtual Screening for Drug Discovery Market Size (2021–2032)
7.2 Europe Virtual Screening for Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Virtual Screening for Drug Discovery Market Size by Country (2021–2026)
7.4 Europe Virtual Screening for Drug Discovery Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Virtual Screening for Drug Discovery Market Size (2021–2032)
8.2 Asia-Pacific Virtual Screening for Drug Discovery Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Virtual Screening for Drug Discovery Market Size by Region (2021–2026)
8.4 Asia-Pacific Virtual Screening for Drug Discovery Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Virtual Screening for Drug Discovery Market Size (2021–2032)
9.2 Latin America Virtual Screening for Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Virtual Screening for Drug Discovery Market Size by Country (2021–2026)
9.4 Latin America Virtual Screening for Drug Discovery Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Virtual Screening for Drug Discovery Market Size (2021–2032)
10.2 Middle East & Africa Virtual Screening for Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Virtual Screening for Drug Discovery Market Size by Country (2021–2026)
10.4 Middle East & Africa Virtual Screening for Drug Discovery Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MedChemExpress
11.1.1 MedChemExpress Company Details
11.1.2 MedChemExpress Business Overview
11.1.3 MedChemExpress Virtual Screening for Drug Discovery Introduction
11.1.4 MedChemExpress Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.1.5 MedChemExpress Recent Development
11.2 TargetMol
11.2.1 TargetMol Company Details
11.2.2 TargetMol Business Overview
11.2.3 TargetMol Virtual Screening for Drug Discovery Introduction
11.2.4 TargetMol Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.2.5 TargetMol Recent Development
11.3 OpenEye Scientific
11.3.1 OpenEye Scientific Company Details
11.3.2 OpenEye Scientific Business Overview
11.3.3 OpenEye Scientific Virtual Screening for Drug Discovery Introduction
11.3.4 OpenEye Scientific Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.3.5 OpenEye Scientific Recent Development
11.4 Eurofins Discovery
11.4.1 Eurofins Discovery Company Details
11.4.2 Eurofins Discovery Business Overview
11.4.3 Eurofins Discovery Virtual Screening for Drug Discovery Introduction
11.4.4 Eurofins Discovery Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.4.5 Eurofins Discovery Recent Development
11.5 Sygnature Discovery
11.5.1 Sygnature Discovery Company Details
11.5.2 Sygnature Discovery Business Overview
11.5.3 Sygnature Discovery Virtual Screening for Drug Discovery Introduction
11.5.4 Sygnature Discovery Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.5.5 Sygnature Discovery Recent Development
11.6 Jubilant Biosys
11.6.1 Jubilant Biosys Company Details
11.6.2 Jubilant Biosys Business Overview
11.6.3 Jubilant Biosys Virtual Screening for Drug Discovery Introduction
11.6.4 Jubilant Biosys Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.6.5 Jubilant Biosys Recent Development
11.7 Schrödinger, Inc.
11.7.1 Schrödinger, Inc. Company Details
11.7.2 Schrödinger, Inc. Business Overview
11.7.3 Schrödinger, Inc. Virtual Screening for Drug Discovery Introduction
11.7.4 Schrödinger, Inc. Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.7.5 Schrödinger, Inc. Recent Development
11.8 Cresset Group
11.8.1 Cresset Group Company Details
11.8.2 Cresset Group Business Overview
11.8.3 Cresset Group Virtual Screening for Drug Discovery Introduction
11.8.4 Cresset Group Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.8.5 Cresset Group Recent Development
11.9 ComputaBio
11.9.1 ComputaBio Company Details
11.9.2 ComputaBio Business Overview
11.9.3 ComputaBio Virtual Screening for Drug Discovery Introduction
11.9.4 ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.9.5 ComputaBio Recent Development
11.10 Profacgen
11.10.1 Profacgen Company Details
11.10.2 Profacgen Business Overview
11.10.3 Profacgen Virtual Screening for Drug Discovery Introduction
11.10.4 Profacgen Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.10.5 Profacgen Recent Development
11.11 CD ComputaBio
11.11.1 CD ComputaBio Company Details
11.11.2 CD ComputaBio Business Overview
11.11.3 CD ComputaBio Virtual Screening for Drug Discovery Introduction
11.11.4 CD ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.11.5 CD ComputaBio Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Details
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Virtual Screening for Drug Discovery Introduction
11.12.4 Creative Biolabs Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.12.5 Creative Biolabs Recent Development
11.13 BOC Sciences
11.13.1 BOC Sciences Company Details
11.13.2 BOC Sciences Business Overview
11.13.3 BOC Sciences Virtual Screening for Drug Discovery Introduction
11.13.4 BOC Sciences Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.13.5 BOC Sciences Recent Development
11.14 CKTTDB
11.14.1 CKTTDB Company Details
11.14.2 CKTTDB Business Overview
11.14.3 CKTTDB Virtual Screening for Drug Discovery Introduction
11.14.4 CKTTDB Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.14.5 CKTTDB Recent Development
11.15 HitGen
11.15.1 HitGen Company Details
11.15.2 HitGen Business Overview
11.15.3 HitGen Virtual Screening for Drug Discovery Introduction
11.15.4 HitGen Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.15.5 HitGen Recent Development
11.16 WuXi AppTec
11.16.1 WuXi AppTec Company Details
11.16.2 WuXi AppTec Business Overview
11.16.3 WuXi AppTec Virtual Screening for Drug Discovery Introduction
11.16.4 WuXi AppTec Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.16.5 WuXi AppTec Recent Development
11.17 LeadBuilder
11.17.1 LeadBuilder Company Details
11.17.2 LeadBuilder Business Overview
11.17.3 LeadBuilder Virtual Screening for Drug Discovery Introduction
11.17.4 LeadBuilder Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.17.5 LeadBuilder Recent Development
11.18 CSNpharm
11.18.1 CSNpharm Company Details
11.18.2 CSNpharm Business Overview
11.18.3 CSNpharm Virtual Screening for Drug Discovery Introduction
11.18.4 CSNpharm Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.18.5 CSNpharm Recent Development
11.19 ChemNavigator
11.19.1 ChemNavigator Company Details
11.19.2 ChemNavigator Business Overview
11.19.3 ChemNavigator Virtual Screening for Drug Discovery Introduction
11.19.4 ChemNavigator Revenue in Virtual Screening for Drug Discovery Business (2021–2026)
11.19.5 ChemNavigator Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Virtual Screening for Drug Discovery Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Structure-based Virtual Screening (SBVS)
Table 3. Key Players of Ligand-based Virtual Screening (LBVS)
Table 4. Key Players of Hybrid Methods
Table 5. Global Virtual Screening for Drug Discovery Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Virtual Screening for Drug Discovery Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Virtual Screening for Drug Discovery Market Size by Region (US$ Million), 2021–2026
Table 8. Global Virtual Screening for Drug Discovery Market Share by Region (2021–2026)
Table 9. Global Virtual Screening for Drug Discovery Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Virtual Screening for Drug Discovery Market Share by Region (2027–2032)
Table 11. Virtual Screening for Drug Discovery Market Trends
Table 12. Virtual Screening for Drug Discovery Market Drivers
Table 13. Virtual Screening for Drug Discovery Market Challenges
Table 14. Virtual Screening for Drug Discovery Market Restraints
Table 15. Global Virtual Screening for Drug Discovery Revenue by Players (US$ Million), 2021–2026
Table 16. Global Virtual Screening for Drug Discovery Market Share by Players (2021–2026)
Table 17. Global Top Virtual Screening for Drug Discovery Players by Tier (Tier 1, Tier 2, and Tier 3), based on Virtual Screening for Drug Discovery Revenue, 2025
Table 18. Ranking of Global Top Virtual Screening for Drug Discovery Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Virtual Screening for Drug Discovery Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Virtual Screening for Drug Discovery, Headquarters and Area Served
Table 21. Global Key Players of Virtual Screening for Drug Discovery, Products and Applications
Table 22. Global Key Players of Virtual Screening for Drug Discovery, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Virtual Screening for Drug Discovery Market Size by Type (US$ Million), 2021–2026
Table 25. Global Virtual Screening for Drug Discovery Revenue Market Share by Type (2021–2026)
Table 26. Global Virtual Screening for Drug Discovery Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Virtual Screening for Drug Discovery Revenue Market Share by Type (2027–2032)
Table 28. Global Virtual Screening for Drug Discovery Market Size by Application (US$ Million), 2021–2026
Table 29. Global Virtual Screening for Drug Discovery Revenue Market Share by Application (2021–2026)
Table 30. Global Virtual Screening for Drug Discovery Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Virtual Screening for Drug Discovery Revenue Market Share by Application (2027–2032)
Table 32. North America Virtual Screening for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Virtual Screening for Drug Discovery Market Size by Country (US$ Million), 2021–2026
Table 34. North America Virtual Screening for Drug Discovery Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Virtual Screening for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Virtual Screening for Drug Discovery Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Virtual Screening for Drug Discovery Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Virtual Screening for Drug Discovery Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Virtual Screening for Drug Discovery Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Virtual Screening for Drug Discovery Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Virtual Screening for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Virtual Screening for Drug Discovery Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Virtual Screening for Drug Discovery Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Virtual Screening for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Virtual Screening for Drug Discovery Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Virtual Screening for Drug Discovery Market Size by Country (US$ Million), 2027–2032
Table 47. MedChemExpress Company Details
Table 48. MedChemExpress Business Overview
Table 49. MedChemExpress Virtual Screening for Drug Discovery Product
Table 50. MedChemExpress Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 51. MedChemExpress Recent Development
Table 52. TargetMol Company Details
Table 53. TargetMol Business Overview
Table 54. TargetMol Virtual Screening for Drug Discovery Product
Table 55. TargetMol Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 56. TargetMol Recent Development
Table 57. OpenEye Scientific Company Details
Table 58. OpenEye Scientific Business Overview
Table 59. OpenEye Scientific Virtual Screening for Drug Discovery Product
Table 60. OpenEye Scientific Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 61. OpenEye Scientific Recent Development
Table 62. Eurofins Discovery Company Details
Table 63. Eurofins Discovery Business Overview
Table 64. Eurofins Discovery Virtual Screening for Drug Discovery Product
Table 65. Eurofins Discovery Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 66. Eurofins Discovery Recent Development
Table 67. Sygnature Discovery Company Details
Table 68. Sygnature Discovery Business Overview
Table 69. Sygnature Discovery Virtual Screening for Drug Discovery Product
Table 70. Sygnature Discovery Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 71. Sygnature Discovery Recent Development
Table 72. Jubilant Biosys Company Details
Table 73. Jubilant Biosys Business Overview
Table 74. Jubilant Biosys Virtual Screening for Drug Discovery Product
Table 75. Jubilant Biosys Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 76. Jubilant Biosys Recent Development
Table 77. Schrödinger, Inc. Company Details
Table 78. Schrödinger, Inc. Business Overview
Table 79. Schrödinger, Inc. Virtual Screening for Drug Discovery Product
Table 80. Schrödinger, Inc. Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 81. Schrödinger, Inc. Recent Development
Table 82. Cresset Group Company Details
Table 83. Cresset Group Business Overview
Table 84. Cresset Group Virtual Screening for Drug Discovery Product
Table 85. Cresset Group Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 86. Cresset Group Recent Development
Table 87. ComputaBio Company Details
Table 88. ComputaBio Business Overview
Table 89. ComputaBio Virtual Screening for Drug Discovery Product
Table 90. ComputaBio Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 91. ComputaBio Recent Development
Table 92. Profacgen Company Details
Table 93. Profacgen Business Overview
Table 94. Profacgen Virtual Screening for Drug Discovery Product
Table 95. Profacgen Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 96. Profacgen Recent Development
Table 97. CD ComputaBio Company Details
Table 98. CD ComputaBio Business Overview
Table 99. CD ComputaBio Virtual Screening for Drug Discovery Product
Table 100. CD ComputaBio Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 101. CD ComputaBio Recent Development
Table 102. Creative Biolabs Company Details
Table 103. Creative Biolabs Business Overview
Table 104. Creative Biolabs Virtual Screening for Drug Discovery Product
Table 105. Creative Biolabs Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 106. Creative Biolabs Recent Development
Table 107. BOC Sciences Company Details
Table 108. BOC Sciences Business Overview
Table 109. BOC Sciences Virtual Screening for Drug Discovery Product
Table 110. BOC Sciences Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 111. BOC Sciences Recent Development
Table 112. CKTTDB Company Details
Table 113. CKTTDB Business Overview
Table 114. CKTTDB Virtual Screening for Drug Discovery Product
Table 115. CKTTDB Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 116. CKTTDB Recent Development
Table 117. HitGen Company Details
Table 118. HitGen Business Overview
Table 119. HitGen Virtual Screening for Drug Discovery Product
Table 120. HitGen Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 121. HitGen Recent Development
Table 122. WuXi AppTec Company Details
Table 123. WuXi AppTec Business Overview
Table 124. WuXi AppTec Virtual Screening for Drug Discovery Product
Table 125. WuXi AppTec Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 126. WuXi AppTec Recent Development
Table 127. LeadBuilder Company Details
Table 128. LeadBuilder Business Overview
Table 129. LeadBuilder Virtual Screening for Drug Discovery Product
Table 130. LeadBuilder Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 131. LeadBuilder Recent Development
Table 132. CSNpharm Company Details
Table 133. CSNpharm Business Overview
Table 134. CSNpharm Virtual Screening for Drug Discovery Product
Table 135. CSNpharm Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 136. CSNpharm Recent Development
Table 137. ChemNavigator Company Details
Table 138. ChemNavigator Business Overview
Table 139. ChemNavigator Virtual Screening for Drug Discovery Product
Table 140. ChemNavigator Revenue in Virtual Screening for Drug Discovery Business (US$ Million), 2021–2026
Table 141. ChemNavigator Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
Table 145. Authors List of This Report
List of Figures
Figure 1. Virtual Screening for Drug Discovery Picture
Figure 2. Global Virtual Screening for Drug Discovery Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Virtual Screening for Drug Discovery Market Share by Type: 2025 vs 2032
Figure 4. Structure-based Virtual Screening (SBVS) Features
Figure 5. Ligand-based Virtual Screening (LBVS) Features
Figure 6. Hybrid Methods Features
Figure 7. Global Virtual Screening for Drug Discovery Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Virtual Screening for Drug Discovery Market Share by Application: 2025 vs 2032
Figure 9. Pharmaceutical Company Case Studies
Figure 10. Universities and Research Institutions Case Studies
Figure 11. Others Case Studies
Figure 12. Virtual Screening for Drug Discovery Report Years Considered
Figure 13. Global Virtual Screening for Drug Discovery Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Virtual Screening for Drug Discovery Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Virtual Screening for Drug Discovery Market Share by Region: 2025 vs 2032
Figure 16. Global Virtual Screening for Drug Discovery Market Share by Players in 2025
Figure 17. Global Virtual Screening for Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Virtual Screening for Drug Discovery Revenue in 2025
Figure 19. North America Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Virtual Screening for Drug Discovery Market Share by Country (2021–2032)
Figure 21. United States Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Virtual Screening for Drug Discovery Market Share by Country (2021–2032)
Figure 25. Germany Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Virtual Screening for Drug Discovery Market Share by Region (2021–2032)
Figure 33. China Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Virtual Screening for Drug Discovery Market Share by Country (2021–2032)
Figure 41. Mexico Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Virtual Screening for Drug Discovery Market Share by Country (2021–2032)
Figure 45. Israel Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Virtual Screening for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. MedChemExpress Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 49. TargetMol Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 50. OpenEye Scientific Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 51. Eurofins Discovery Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 52. Sygnature Discovery Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 53. Jubilant Biosys Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 54. Schrödinger, Inc. Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 55. Cresset Group Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 56. ComputaBio Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 57. Profacgen Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 58. CD ComputaBio Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 59. Creative Biolabs Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 60. BOC Sciences Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 61. CKTTDB Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 62. HitGen Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 63. WuXi AppTec Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 64. LeadBuilder Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 65. CSNpharm Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 66. ChemNavigator Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021–2026)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
